ScienceDex / Researcher record
Daniela Annenelie Bota
- University of California-Irvine · Neurology (NIH department code)
- University of California-Irvine · Internal Medicine (NIH department code)
From the FY2024 NIH awards this investigator leads as contact PI. The department is the award's.
- R01 Holder
- Early Career
NIH Funding · FY2024
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2024 | $1,212,750 | 7 | #11,880 |
| 2025 | $764,642 | 3 | #21,186 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY2024 · selected7 records
- FY20253 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 10115491Search this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2024 through FY2025Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2027.
FY2025 award categories
- Neurology
- Internal Medicine
FY2024 award records by amount
NIH award records listing Daniela Annenelie Bota as a PI. Multi-PI records show the full award amount for context.
- 5R01CA263806-04R01Contact PITargeting p38/JNK MAPK to ameliorate cisplatin-induced adverse sequelae on the nervous systemUniversity of California-Irvine · Neurology (NIH department code)$574.8Kaward amount
- 5R01NS109423-05R01Contact PITargeting of Mitochondrial Lon Protease as a Novel Therapy for GlioblastomaUniversity of California-Irvine · Internal Medicine (NIH department code)$399.3Kaward amount
- 3R01CA263806-04S2R01Contact PITargeting p38/JNK MAPK to ameliorate cisplatin-induced adverse sequelae on the nervous systemUniversity of California-Irvine · Neurology (NIH department code)$95.5Kaward amount
- 3R01CA263806-04S1R01Contact PITargeting p38/JNK MAPK to ameliorate cisplatin-induced adverse sequelae on the nervous systemUniversity of California-Irvine · Neurology (NIH department code)$82.5Kaward amount
- 3R01CA263806-03S1R01Contact PISupplement to Promote Diversity: Targeting p38/JNK MAPK to ameliorate cisplatin-induced adverse sequelae on the nervous systemUniversity of California-Irvine · Neurology (NIH department code)$33.1Kaward amount
- 3R01CA263806-03S2R01Contact PISupplement to Promote Diversity:Targeting p38/JNK MAPK to ameliorate cisplatin-induced adverse sequelae on the nervous systemUniversity of California-Irvine · Neurology (NIH department code)$18.3Kaward amount
- 3R01NS109423-05S1R01Contact PITargeting of Mitochondrial Lon Protease as a Novel Therapy for GlioblastomaUniversity of California-Irvine · Internal Medicine (NIH department code)$9.1Kaward amount
Award organization
Organizations that administered FY2024 awards listing Daniela Annenelie Bota as a PI.
FY2024 award administered by University of California-Irvine (CA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardUniversity of California-Irvine
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024R01 Grant Holder
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Daniela Annenelie Bota.